Cupricchloride

Base Information

• Chemical Name: Cupricchloride
• CAS No.: 7447-39-4
• Deprecated CAS: 423724-63-4
• Molecular Formula: CuCl2
• Molecular Weight: 134.452
• Hs Code.: 28274990
• UNII: P484053J2Y
• DSSTox Substance ID: DTXSID7040449
• Nikkaji Number: J43.795F
• Mol file: 7447-39-4.mol

Synonyms:copper;dichloride;DTXSID7040449;Cupricchloride;CUPRIC CHLORIDE [MI];Copper(II) Chloride Anhydrous;DTXCID5020449;COPPER CHLORIDE [WHO-DD];Tox21_202868;AKOS030228632;CUPRIC CHLORIDE ANHYDROUS [HSDB];NCGC00260414-01;CAS-7447-39-4;C3714

Chemical Property of Cupricchloride

Chemical Property:

• Appearance/Colour: Brownish yellow crystalline powder
• Melting Point: 498 °C
• Boiling Point: 993 °C
• PSA: 0.00000
• Density: 3.386 g/cm³
• LogP: -5.99450
• Water Solubility.: 620 g/L (20℃)
• Hydrogen Bond Donor Count: 0
• Hydrogen Bond Acceptor Count: 2
• Rotatable Bond Count: 0
• Exact Mass: 132.867303
• Heavy Atom Count: 3
• Complexity: 0

Purity/Quality:

98% ^*data from raw suppliers

Safty Information:

• Pictogram(s): T, N
• Hazard Codes: T:Toxic;;
• Statements: R25:; R36/37/38:; R50/53:
• Safety Statements: S26:; S29:; S37/39:; S45:; S57:

MSDS Files:

SDS file from LookChem

Total 1 MSDS from other Authors

Useful:

• Canonical SMILES: [Cl-].[Cl-].[Cu+2]

Technology Process of Cupricchloride

There total 2 articles about Cupricchloride which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:

Reference yield:

chlorine (7782-50-5) + copper(l) chloride → copper(II) chloride (7447-39-4)

Guidance literature:

In gaseous matrix; passing of Cl2 in Ar gas (5%) over solid Cu(I)Cl (650°C, alumina crucible, backing pressure 1.5 atm);

DOI:10.1039/ft9938903205

Reference yield:

chlorine (7782-50-5) + copper (12775-96-1,15158-11-9,15721-63-8,16941-75-6,17493-86-6,19498-52-3,20499-83-6,20499-84-7,20499-85-8,20499-86-9,20573-10-8,20573-11-9,21595-51-7,21595-52-8,22206-52-6,26445-28-3,28959-95-7,37362-93-9,39417-05-5,54603-16-6,54603-23-5,54603-32-6,54603-40-6,54603-48-4,54603-81-5,54603-89-3,56316-56-4,95985-91-4,122297-32-9,7440-50-8) → copper(II) chloride (7447-39-4)

Guidance literature:

In neat (no solvent); copper wire was heated in a small excess of Cl2 in a sealed cell;;

DOI:10.1016/0301-0104(93)85088-P

Reference yield: 100.0%

1-Decene (872-05-9,17438-89-0,25189-70-2) + magnesium sulfate (7487-88-9) + copper(II) chloride (7447-39-4) + palladium dichloride → 2-methyl decanoic acid (24323-23-7)

Guidance literature:

With hydrogenchloride; carbon monoxide; In tetrahydrofuran; sodium hydroxide; water;

upstream raw materials:

chlorine

copper

Downstream raw materials:

2-Chloro-5-nitropyrimidine

N-[4-chloro-2-fluoro-5-(2-hydroxyphenoxy)phenyl]acetamide

([4-{2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-1,2,3,6-tetrahydropyrimidin-1-yl]phenoxy}phenoxy]methyl)benzene

([3-{2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-1,2,3,6-tetrahydropyrimidin-1-yl]phenoxy}phenoxy]methyl)benzene

Refernces

Synthesis and biological screening of some fluorinated dibenzofuran containing 3-chlorochromones and benzothiazepines

10.1002/jhet.139

The research explores the synthesis and biological evaluation of fluorinated dibenzofuran derivatives. The study aims to investigate the impact of incorporating fluorine into organic molecules on their pharmacological properties, specifically focusing on their potential antimicrobial, antiviral, and antioxidant activities. Key chemicals used in the research include 4-difluoromethoxy-dibenzofuran-1-carboxaldehyde, various 2-hydroxy acetophenones, copper chloride, and 2-aminothiophenol. The synthesized compounds were subjected to biological screening, which revealed that none of the tested compounds exhibited significant antioxidant, antimicrobial, or antiviral activities. The study concludes that while fluorine incorporation is known to enhance pharmacological properties in many compounds, the specific derivatives synthesized in this study did not demonstrate the expected biological activities. This suggests that further modifications or different synthetic approaches may be necessary to achieve the desired biological effects.